rs201866844
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000216.4(ANOS1):c.1354+19_1354+22delCTTA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00748 in 1,187,970 control chromosomes in the GnomAD database, including 411 homozygotes. There are 2,314 hemizygotes in GnomAD. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.038 ( 208 hom., 1137 hem., cov: 21)
Exomes 𝑓: 0.0043 ( 203 hom. 1177 hem. )
Consequence
ANOS1
NM_000216.4 intron
NM_000216.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0330
Genes affected
ANOS1 (HGNC:6211): (anosmin 1) Mutations in this gene cause the X-linked Kallmann syndrome. The encoded protein is similar in sequence to proteins known to function in neural cell adhesion and axonal migration. In addition, this cell surface protein is N-glycosylated and may have anti-protease activity. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant X-8553929-ATAAG-A is Benign according to our data. Variant chrX-8553929-ATAAG-A is described in ClinVar as [Benign]. Clinvar id is 516595.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.131 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANOS1 | NM_000216.4 | c.1354+19_1354+22delCTTA | intron_variant | ENST00000262648.8 | NP_000207.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANOS1 | ENST00000262648.8 | c.1354+19_1354+22delCTTA | intron_variant | 1 | NM_000216.4 | ENSP00000262648.3 |
Frequencies
GnomAD3 genomes AF: 0.0380 AC: 4255AN: 111959Hom.: 207 Cov.: 21 AF XY: 0.0328 AC XY: 1119AN XY: 34149
GnomAD3 genomes
AF:
AC:
4255
AN:
111959
Hom.:
Cov.:
21
AF XY:
AC XY:
1119
AN XY:
34149
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0106 AC: 1932AN: 182742Hom.: 77 AF XY: 0.00688 AC XY: 463AN XY: 67268
GnomAD3 exomes
AF:
AC:
1932
AN:
182742
Hom.:
AF XY:
AC XY:
463
AN XY:
67268
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00428 AC: 4610AN: 1075962Hom.: 203 AF XY: 0.00342 AC XY: 1177AN XY: 343952
GnomAD4 exome
AF:
AC:
4610
AN:
1075962
Hom.:
AF XY:
AC XY:
1177
AN XY:
343952
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0382 AC: 4278AN: 112008Hom.: 208 Cov.: 21 AF XY: 0.0332 AC XY: 1137AN XY: 34208
GnomAD4 genome
AF:
AC:
4278
AN:
112008
Hom.:
Cov.:
21
AF XY:
AC XY:
1137
AN XY:
34208
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
28
AN:
2522
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 13, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Hypogonadotropic hypogonadism 1 with or without anosmia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 02, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at